These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25532003)

  • 1. The use of mebeverine in irritable bowel syndrome. A Position paper of the Romanian Society of Neurogastroenterology based on evidence.
    Dumitrascu DL; Chira A; Bataga S; Diculescu M; Drug V; Gheorghe C; Goldis A; Nedelcu L; Porr PJ; Sporea I;
    J Gastrointestin Liver Dis; 2014 Dec; 23(4):431-5. PubMed ID: 25532003
    [No Abstract]   [Full Text] [Related]  

  • 2. American Gastroenterological Association Institute Technical Review on the pharmacological management of irritable bowel syndrome.
    Chang L; Lembo A; Sultan S
    Gastroenterology; 2014 Nov; 147(5):1149-72.e2. PubMed ID: 25224525
    [No Abstract]   [Full Text] [Related]  

  • 3. American Gastroenterological Association Institute Guideline on the pharmacological management of irritable bowel syndrome.
    Weinberg DS; Smalley W; Heidelbaugh JJ; Sultan S;
    Gastroenterology; 2014 Nov; 147(5):1146-8. PubMed ID: 25224526
    [No Abstract]   [Full Text] [Related]  

  • 4. How can we achieve relief of bowel and abdominal symptoms for patients with irritable bowel syndrome with constipation?
    Tack J
    Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5 Suppl 1):21-6. PubMed ID: 23859757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug treatment for irritable bowel syndrome].
    Hillilä M; Färkkilä M
    Duodecim; 2004; 120(20):2453-8. PubMed ID: 15641514
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality of life in patients with irritable bowel syndrome.
    Mönnikes H
    J Clin Gastroenterol; 2011 Aug; 45 Suppl():S98-101. PubMed ID: 21666428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of cognitive behaviour therapy in addition to mebeverine for irritable bowel syndrome.
    McCrone P; Knapp M; Kennedy T; Seed P; Jones R; Darnley S; Chalder T
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):255-63. PubMed ID: 18334867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of irritable bowel syndrome using a selected herbal combination of Iraqi folk medicines.
    Sahib AS
    J Ethnopharmacol; 2013 Jul; 148(3):1008-12. PubMed ID: 23707209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and safety of trimebutine versus mebeverine in the treatment of irritable bowel syndrome.
    Rahman MZ; Ahmed DS; Mahmuduzzaman M; Rahman MA; Chowdhury MS; Barua R; Ishaque SM
    Mymensingh Med J; 2014 Jan; 23(1):105-13. PubMed ID: 24584382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy options in irritable bowel syndrome.
    Enck P; Junne F; Klosterhalfen S; Zipfel S; Martens U
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1402-11. PubMed ID: 21389791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irritable bowel syndrome and small intestinal bacterial overgrowth.
    Yamini D; Pimentel M
    J Clin Gastroenterol; 2010; 44(10):672-5. PubMed ID: 20838236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of treatment outcome after cognitive behavior therapy and antispasmodic treatment for patients with irritable bowel syndrome in primary care.
    Reme SE; Kennedy T; Jones R; Darnley S; Chalder T
    J Psychosom Res; 2010 Apr; 68(4):385-8. PubMed ID: 20307706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prospects for using ladasten preparations in patients with irritable bowel syndrome].
    Uspenskiĭ IuP; Fominykh IuA
    Eksp Klin Gastroenterol; 2010; (10):75-9. PubMed ID: 21434378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Irritable bowel syndrome: issues of diagnosis and treatment efficiency].
    Loranskaia ID
    Eksp Klin Gastroenterol; 2008; (1):90-5. PubMed ID: 19145859
    [No Abstract]   [Full Text] [Related]  

  • 15. A review of irritable bowel syndrome and an update on therapeutic approaches.
    Bassett JT; Cash BD
    Expert Opin Pharmacother; 2008 May; 9(7):1129-43. PubMed ID: 18422471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.
    Lee KJ; Kim NY; Kwon JK; Huh KC; Lee OY; Lee JS; Choi SC; Sohn CI; Myung SJ; Park HJ; Choi MK; Bak YT; Rhee PL
    Neurogastroenterol Motil; 2011 Dec; 23(12):1098-104. PubMed ID: 21920001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome.
    Darvish-Damavandi M; Nikfar S; Abdollahi M
    World J Gastroenterol; 2010 Feb; 16(5):547-53. PubMed ID: 20128021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs for irritable bowel syndrome.
    Treat Guidel Med Lett; 2011 Jul; 9(107):41-6. PubMed ID: 21701443
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment options for irritable bowel syndrome.
    Harmon HW
    Nurse Pract; 2007 Jul; 32(7):39-43. PubMed ID: 17595589
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical practice guideline for irritable bowel syndrome].
    Tort S; Balboa A; Marzo M; Carrillo R; Mínguez M; Valdepérez J; Alonso-Coello P; Mascort JJ; Ferrándiz J; Bonfill X; Piqué JM; Mearin F; ; ;
    Gastroenterol Hepatol; 2006 Oct; 29(8):467-521. PubMed ID: 17020681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.